ASTELLAS PHARMA US H-1B Visa Sponsorship & Salary Data

The median H-1B salary at ASTELLAS PHARMA US is $147,000, based on 24 certified filings from FY 2020 to FY 2026. This is 23% higher than the national H-1B median salary of $120,000. Compensation at ASTELLAS PHARMA US reflects their market positioning, with entry-level roles starting around $130,000 and senior positions reaching $214,772 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at ASTELLAS PHARMA US range from $115,500 at the 10th percentile to $214,772 at the 90th percentile, showing a $99,272 spread across experience levels and roles. The 25th percentile is $130,000 and the 75th percentile is $186,582.

Yes, ASTELLAS PHARMA US actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 25 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 24 certified applications and a 0% denial rate, ASTELLAS PHARMA US maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), ASTELLAS PHARMA US filed 1 H-1B applications, with 1 certified and 0 denied. Over 7 years of data, ASTELLAS PHARMA US has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

ASTELLAS PHARMA US's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 25 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating ASTELLAS PHARMA US as a potential H-1B sponsor.

This is an excellent approval rate, indicating ASTELLAS PHARMA US has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

ASTELLAS PHARMA US sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 24 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles ASTELLAS PHARMA US most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at ASTELLAS PHARMA US:

The most frequently sponsored role is Lead, Oncology Brand Analytics with 2 filings at a median salary of $190,000. This is followed by Manager, Cet Business Insights And Reporting (1 filings) and Associate Manager, Business Analytics.

ASTELLAS PHARMA US's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where ASTELLAS PHARMA US sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top ASTELLAS PHARMA US H-1B locations:

The largest H-1B hub for ASTELLAS PHARMA US is Northbrook, IL with 20 filings at a median salary of $147,000. The highest-paying location is Medford, MA at $190,000 median. Salaries range from $130,000 to $190,000 across office locations.

ASTELLAS PHARMA US's median H-1B salary has increased by +67% from FY 2020 ($147,000) to FY 2026 ($245,505). Tracking salary trends over time reveals how ASTELLAS PHARMA US adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at ASTELLAS PHARMA US.

Year-by-year breakdown:

• FY 2022: $141,000 (2 certified)
• FY 2023: $165,000 (4 certified)
• FY 2024: $172,507 (3 certified)
• FY 2025: $190,000 (6 certified)
• FY 2026: $245,505 (1 certified)

This 67% growth reflects strong compensation adjustments at ASTELLAS PHARMA US, keeping pace with market demands for H-1B talent.

ASTELLAS PHARMA US primarily files H-1B applications at Wage Level IV, accounting for 58% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making ASTELLAS PHARMA US's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 92% of positions at Level II or higher, ASTELLAS PHARMA US typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

ASTELLAS PHARMA US's median H-1B salary of $147,000 is 23% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating ASTELLAS PHARMA US's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare ASTELLAS PHARMA US's offerings with similar companies in your field for a more accurate assessment.

This places ASTELLAS PHARMA US among the higher-paying H-1B sponsors in the industry. Candidates considering H-1B sponsorship should weigh this competitive compensation alongside other factors like role growth, location, and visa processing track record.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. ASTELLAS PHARMA US's higher proportion of Level III-IV positions (75%) may benefit from wage-based lottery prioritization.

With 24 certified filings, ASTELLAS PHARMA US invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.